Peptide Therapy Forms
Peptide Therapy Clinic Bundle
The complete documentation system for peptide practices: five substance-specific informed consents (BPC-157, CJC-1295/Ipamorelin, Sermorelin, NAD+, Glutathione),…
NAD+ Consent & Intake Form
Substance-specific informed consent for NAD+ injections and infusions — including rate-dependent infusion reactions and honest compounded-medication language.
BPC-157 Consent & Intake Form
An honest, thorough BPC-157 consent: investigational status, FDA compounding category history, unknown long-term effects — the disclosure serious clinics actually…
GH Peptides Consent Pack
Three complete growth-hormone-secretagogue consents in one pack — each with its own current regulatory story, from Sermorelin's discontinued-approval history to…
Sermorelin Consent Form
Standalone Sermorelin informed consent with accurate regulatory framing (former FDA-approved drug, compounded today) and GH-axis risk language.
CJC-1295 / Ipamorelin Consent Form
Blend-specific informed consent for the most-prescribed GH peptide combination, current to the 2023-24 FDA compounding review.
Glutathione Consent Form
IV/IM glutathione consent with sulfite-sensitivity cautions and the 2019 FDA compounding alert reflected — not a generic vitamin form with the name swapped.
